Read all about Erganeo in our September newsletter :

▪ New MRI data interpretation method revolutionizes liver fibrosis detection.
▪ Start-up Orixha obtains ANSM authorization to launch its clinical feasibility study in post-cardiac arrest syndrome.
▪ Discover the innovations supported by Erganeo, responding to the Sustainable Development Goals.
▪ The Sci-ty support program continues its call for projects until October 30.
▪ Start-up Persea joins the Deeptech à fonds program offered by Bpifrance.

Read the September 2024 newsletter